Company Search:
Advanced Search
Sponsored Links
Pcas SA Company Snapshot
Pcas SA operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pcas SA with three other pharmaceutical manufacturers in Europe: Vectura Group PLC of the United Kingdom (2017 sales of £148.00 million [US$188.54 million] of which 100% was Pharmaceutical Prod), Evotec AG of Germany (257.63 million Euro [US$292.10 million] of which 83% was EVT Execute), and Laboratorio Reig Jofre SA which is based in Spain (167.98 million Euro [US$190.46 million] of which 85% was Sale of Pharmaceutical Products).

Sales Analysis. During the year ended December of 2017, sales at Pcas SA were 218.27 million Euro (US$247.47 million). This is an increase of 13.7% versus 2016, when the company's sales were 191.99 million Euro. This was the fourth straight year of sales growth at Pcas SA. Sales of Pharmaceutical Synthesis saw an increase of 14.6% in 2017, from 129.97 million Euro to 148.94 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Pcas SA
  Stock Performance Chart for Pcas SA
  Stock Data: Recent Stock Performance:
  Current Price (12/7/2018): 13.00
(Figures in Euro)
1 Week 0.0%   13 Weeks -7.9%  
4 Weeks -19.7%   52 Weeks -29.1%  
Pcas SA Key Data:
  Ticker: PCA Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 218,270,000
(Year Ending Jan 2018).
Employees: 1,071
  Currency: Euro Market Cap: 182,436,254
  Fiscal Yr Ends: December Shares Outstanding: 14,033,558
  Share Type: Actions Ordinaires Closely Held Shares: 11,806,447
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.